Alterations of RASSF1A in premalignant cervical lesions: Clinical and prognostic significance

Molecular Carcinogenesis

Volumn 51, Issue 9, 2012, Pages 723-733

  Mitra, Sraboni ^a   Mazumder Indra, Dipanjana ^a   Basu, Partha S ^a   Mondal, Ranajit K ^a   Roy, Anup ^b   Roychoudhury, Susanta ^c   Panda, Chinmay K ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^b Government of West Bengal   (India)

^c INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

CACNA2D2; CIN; Deletion; Methylation; RASSF1A; RNA; Uterine cervical carcinoma

Indexed keywords

CACNA2D2 PROTEIN; PROTEIN; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CHROMOSOME 3P; CLINICAL ARTICLE; FEMALE; GENE DELETION; GENE EXPRESSION; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; METHYLATION; OVERALL SURVIVAL; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; CALCIUM CHANNELS; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CHROMOSOMES, HUMAN, PAIR 3; DISEASE PROGRESSION; DNA METHYLATION; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PARITY; PRECANCEROUS CONDITIONS; PROGNOSIS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEINS; UTERINE CERVICAL NEOPLASMS;

EID: 84864048733     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20837     Document Type: Article

References (37)

1. Sen U, Sankaranarayanan R, Mandal S, Ramanakumar AV, Parkin DM, Siddiqi M. Cancer patterns in eastern India: The first report of the kolkata cancer registry. Int J Cancer 2002; 100: 86-91.
2. Munoz N, Castellsague X, de Gonzalez AB. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006; 24: S1-S10.
3. Lazo PA. The molecular genetics of cervical carcinoma. Br J Cancer 1999; 80: 2008-2016.
4. Mitra AB, Murty VVVS, Li RG, Pratap M, Luthra UK, Chaganti RSK. Allelotype analysis of cervical carcinoma. Cancer Res 1994; 54: 4481-4487.
5. Mullokandov MR, Kholodilov NG, Atkin NB, Burk RD, Johnson AB, Klinger HP. Genomic alterations in cervical carcinoma: Losses of chromosome heterozygosity and human Papilloma virus tumor status. Cancer Res 1996; 56: 197-205.
6. Larson AA, Kern S, Curtiss S, Gordon R, Cavenee WK, Hampton GM. High resolution analysis of chromosome 3p alterations in cervical carcinoma. Cancer Res 1997; 57: 4082-4090.
7. Atkin NB. Cytogenetics of carcinoma of the cervix uteri: A review. Cancer Genet Cytogenet 1997; 95: 33-39.
8. Allen DG, White DJ, Hutchins AM, et al. Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer. Br J Cancer 2000; 83: 1659-1663.
9. Harris CP, Lu XY, Narayan G, Singh B, Murty VV, Rao PH. Comprehensive molecular cytogenetic characterization of cervical cancer cell lines. Genes Chromosomes Cancer 2003; 36: 233-241.
10. Senchenko V, Liu J, Braga E, Lerman MI, Klein G, Zabarovsky ER. Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomas. Oncogene 2003; 22: 2984-2992.
11. Dasgupta S, Chakraborty SB, Roy A, Roychowdhury S, Panda CK. Differential deletions of chromosome 3p are associated with the development of uterine cervical carcinoma in Indian patients. Mol Pathol 2003; 56: 263-269.
12. Wei MF, Latif F, Bader S, et al. Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: Progress toward the isolation of a lung cancer TSG. Cancer Res 1996; 56: 1487-1492.
13. Agathanggelou A, Honorio S, Macartney DP, et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumors. Oncogene 2001; 20: 1509-1518.
14. Kuroki T, Trapasso F, Yendamuri S, et al. Allele loss and promoter hypermethylation of VHL, RAR-β, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 2003; 63: 3724-3738.
15. Loginov VI, Maliukova AV, Seregin IuA, et al. Methylation of the promoter region of the RASSF1A candidate tumor suppressor gene in primary epithelial tumors. Mol Biol (Mosk) 2004; 38: 654-667.
16. Ghosh S, Ghosh A, Maiti GP, et al. Alterations of 3p21.31 tumor suppressor genes in head and neck squamous cell carcinoma: Correlation with progression and prognosis. Int J Cancer 2008; 123: 2594-2604.
17. Senchenko VN, Anedchenko EA, Kondratieva TT, et al. Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer. BMC Cancer 2010; 10: 75.
18. Donninger H, Vos MD, Clark GJ. The RASSF1A tumor suppressor. J Cell Sci 2007; 120: 3163-3172.
19. Cohen Y, Singer G, Lavie O, Dong SM, Beller U, Sidransky D. The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix. Clin Cancer Res 2003; 9: 2981-2984.
20. Kuzmin I, Liu L, Dammann R, et al. Inactivation of RAS association domain family1A gene in cervical carcinomas and the role of human Papilloma virus infection. Cancer Res 2003; 63: 1888-1893.
21. Narayan G, Arias-Pulido H, Koul S, et al. Frequent promoter methylation of CDH1, DAPK, RARβ, and HIC1 genes in carcinoma of cervix uteri: Its relationship to clinical outcome. Mol Cancer 2003; 2: 24-35.
22. Yu MY, Tong JH, Chan PK, et al. Hypermethylation of the tumor suppressor gene RASSF1A and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers. Int J Cancer 2003; 105: 204-209.
23. Malyukova AV, Loginov WI, Hodyrev DS, et al. Methylation of the putative tumor suppressor gene RASSF1A in primary cervical tumors. Mol Biol 2004; 38: 857-864.
24. Kashuba VI, Pavlova TV, Grigorieva EV, et al. High mutability of the tumor suppressor genes RASSF1 and RBSP3 (CTDSPL) in cancer. PLoS ONE 2009; 4: e5231. DOI: 10.1371/journal.pone.0005231.
25. Carboni GL, Gao B, Nishizaki M, et al. CACNA2D2-mediated apoptosis in NSCLC cells is associated with alterations of the intracellular calcium signaling and disruption of mitochondria membrane integrity. Oncogene 2003; 22: 615-626.
26. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408.
27. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative CT method. Nat Protoc 2008; 3: 1101-1108.
28. Dasgupta S, Mukherjee N, Roy S, et al. Mapping of candidate tumor suppressor genes' loci on human chromosome 3 in head and neck squamous cell carcinoma of an Indian patient population. Oral Oncol 2002; 38: 6-15.
29. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: A laboratory manual, 2nd edition. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory; 1989.
30. Ichimura K, Bolin MB, Goike HM, Schmidt EE, Moshref A, Collins VP. Deregulation of p14ARF/MDM2/p53 pathway is a prerequisite for human astrocytic gliomas with G1-S transition control gene abnormalities. Cancer Res 2000; 60: 417-424.
31. Singh RK, Indra D, Mitra S, et al. Deletions in chromosome 4 differentially associated with the development of cervical cancer: Evidence of SLIT2 as a candidate tumor suppressor gene. Hum Genet 2007; 122: 71-81.
32. Herman JG, Jeremy R, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-9826.
33. Burbee DG, Forgacs E, Zöchbauer-Müller S, et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 2001; 93: 691-699.
34. Singh RK, Dasgupta S, Bhattacharya N, et al. Deletion in chromosome 11 and Bcl-1/CyclinD1 alterations are independently associated with the development of uterine cervical carcinoma. J Cancer Res Clin Oncol 2005; 131: 395-406.
35. Zhang SL, Li N, Ma L, Jiang T. Expression of RASSF1A mRNA and its relationship with HPV-16 in cervical cancer. Zhonghua Yi Xue Za Zhi 2005; 85: 2916-2919 (article in Chinese).
36. Zabarovsky ER, Lerman MI, Minna JD. Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene 2002; 21: 6915-6935.
37. Choi CH, Lee KM, Choi JJ, et al. Hypermethylation and loss of heterozygosity of tumor suppressor genes on chromosome 3p in cervical cancer. Cancer Lett 2007; 255: 26-33.